Eye Point Pharmaceuticals, Inc. reported raising $450,000 in an initial SEC Form D filing, from an offering of $600,000
PUBLIC · EYPTApr 12, 2018$450K of $600K raised
Amount Raised
$450,000
$450,000 sold, per SEC Form D (first sale Apr 12, 2018)
Round Type
Seed
WatertownBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalWho to call at EyePoint, Inc., and when
A new round usually means EyePoint, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EyePoint, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EyePoint, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EyePoint, Inc.. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EyePoint, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Verified contacts10 people are listed at EyePoint, Inc.. We don't have their email yet.See plans and pricing
EyePoint, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.